Nikkei erases early gains as profit-taking offsets upbeat earnings

  • Reuters
  • Stock Market News
Nikkei erases early gains as profit-taking offsets upbeat earnings
Credit: © Reuters.

TOKYO, Jan 29 (Reuters) - Japanese shares slipped on Friday, giving up early gains, as a boost from technology companies reporting upbeat earnings was overshadowed by investors' profit-taking and rebalancing at the end of month.

Still, the market is on course to post its third straight month of gains, with the Nikkei still hovering below a 30-year high touched earlier in the month.

Japan's Nikkei share average .N225 slipped 0.18% to 28,145.63 by midday, after gaining 0.44% earlier in the session. The broader Topix .TOPX was down 0.07% at 1,837.60.

"It appears pension funds are reducing their positions as they change their allocation at the end of month," said a trader at a Japanese brokerage.

That also hit some chip-related shares which had benefited from strong earnings reports.

Advantest 6857.T eased 0.4%, erasing earlier gains of 5.1% after the company raised its profit forecast for the year ending in March, citing strong demand for its chip-testing machines.

Tokyo Electron 8035.T slipped 2.7%, reversing gains of 2.4% after the chip manufacturing machine maker hiked its annual guidance for a second time in the current financial year.

Canon 7751.T fell 5.4%, after gaining about 50% this month as the maker of camera and printer announced a solid earnings growth in the last quarter as expected. some other companies managed to maintain their share gains after reporting strong results. Among tech stocks, Fujitsu 6702.T gained 3.8% and Shinko Electric 6967.T rose 8.9%. Real Estate 3231.T rose 5.7% and Oriental Land 4661.T gained 2.4% following quarterly results which showed a stronger-than-expected recovery of the Tokyo Disney Resort.

JCR Pharma extended its gains to its third day, rising 20.4%, as its upbeat earnings announced on Thursday added to the bullish mood spurred by the news that AstraZeneca AZN.L will license the firm to produce some 90 million doses of its COVID-19 vaccine

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles